Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Has The Gut Microbiota Market Growth Evolved From 2024 To 2025, And What’s Ahead?
The size of the gut microbiota market has seen swift expansion in the past few years. Increasing from $0.55 billion in 2024, it’s projected to expand to $0.65 billion in 2025, indicating a compound annual growth rate (CAGR) of 17.9%. Factors such as the unveil of probiotics and prebiotics, a surge in gastrointestinal conditions, rising interest in functional foods, the escalating usage of antibiotics, and heightened awareness about the gut-brain connection have all contributed to growth during the historical period.
The market for gut microbiota is projected to experience a swift expansion in the coming years, reaching a valuation of $1.25 billion in 2029 with a Compound Annual Growth Rate (CAGR) of 17.9%. The predicted augmentation in the forecast period can be linked to factors such as the increase in personalized nutrition, a surge in demand for microbiome-related therapeutics, growth in the sector of functional and fermented foods, and regulatory encouragement for probiotics and prebiotics. Key trends anticipated in the forecast period include the utilization of artificial Intelligence (AI) for microbiome examination, developments in next-generation sequencing, the use of CRISPR for editing gut microbiota, improvements in intelligent probiotic delivery systems, and the advent of wearable devices specifically designed for monitoring gut health.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=23411&type=smp
How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theGut Microbiota Market?
The surge in personalized medicine demand is believed to be a driving force for the expansion of the gut microbiota market in the future. Personalized medicine is focused on customizing treatments to individual patients, taking into account their genetic makeup, environment, and lifestyle choices. This approach aims to optimize results and enhance care quality. The field of genomics and biotechnology is advancing rapidly, allowing detailed genetic profiling and enabling more effective personalized treatment plans with reduced side effects. Gut microbiota greatly benefits from personalized medicine as it allows treatment procedures to be tailored based on a person’s distinct microbiome composition, thus maximizing gut health and improving outcomes for metabolic and digestive disorders. As an example, the Personalized Medicine Coalition (PMC), a nonprofit organization based in the USA, reported in February 2024 that the U.S. Food and Drug Administration (FDA) authorized 26 personalized medicines in 2023. This figure shows a considerable increase from the 12 endorsements given in the previous year, 2022. Consequently, the booming demand for personalized medicine is stimulating the growth of the gut microbiota market.
Which Segments in the Gut Microbiota Offer the Most Growth?
The gut microbiotamarket covered in this report is segmented –
1) By Product: Prebiotics; Probiotics; Drugs; Supplements; Other Products
2) By Application: Digestive Health; Immune Health; Weight Management; Mental Health; Cardiovascular Health
3) By Distribution Channel: Pharmacies And Drugstores; Online Retail; Health Food Stores; Supermarkets And Hypermarkets; Specialty Stores
4) By End-Users: Adults; Children; Elderly
Subsegments:
1) By Prebiotics: Fructooligosaccharides (Fos); Galactooligosaccharides (Gos); Inulin; Resistant Starch; Beta-Glucans; Arabinogalactans; Pectins
2) By Probiotics: Lactobacillus; Bifidobacterium; Saccharomyces; Streptococcus; Bacillus; Escherichia
3) By Drugs: Antibiotics; Bacteriophage Therapy; Gut Microbiota Modulators; Immunomodulators; Antidiarrheal Agents; Laxatives
4) By Supplements: Synbiotics; Postbiotics; Enzyme Supplements; Vitamin D Supplements; Omega-3 Fatty Acids; Herbal Extracts
5) By Other Products: Functional Foods; Fermented Foods; Beverages; Gut Health Diagnostic Kits; Dietary Fiber Products
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=23411&type=smp
What Are the Fastest-Growing Geographies in the #How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theGut Microbiota Market?# Market?
North America was the largest region in the gut microbiota market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gut microbiota market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Are the Current Market Growth and Trends in the Gut Microbiota Industry?
Key firms in the gut microbiota market are working toward creating groundbreaking solutions such as orally consumed fecal microbiota for treating numerous gastrointestinal issues. This treatment involves taking a pill or capsule that contains useful bacteria sourced from a healthy donor’s stool, with the goal of restoring balance to the gut microbiome. In April 2023, the US firm Seres Therapeutics Inc., a key player in the field of microbiome therapeutics, got FDA approval for Vowst – the very first orally consumed fecal microbiota product. This has been engineered to prevent recurrent C. difficile infection (CDI) in people aged 18 or above, to be used post antibacterial treatment for recurrent CDI. This approval constitutes a critical leap forward in CDI treatment, offering an alternative to traditional fecal microbiota transplants that is not only more accessible but also more patient-friendly, as these are usually administered via enema or colonoscopy. This oral formulation could boost adherence to treatment and widen the acceptance of microbiome-based therapies within the healthcare realm.
View the full report here:
https://www.thebusinessresearchcompany.com/report/gut-microbiota-global-market-report
What Are the Key Elements That Define the Gut Microbiota Market?
Gut microbiota refers to the complex community of microorganisms, including bacteria, viruses, fungi, and other microbes, that reside in the gastrointestinal tract. These microbes play a vital role in digestion, immune function, and overall health by influencing metabolism and protecting against harmful pathogens.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=23411
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model